Economic Burden of Cardiovascular disease in South West of Iran

Sara Emamgholipour; Ali Akbari Sari; Mohsen Pakdaman; Sara Geravandi

International Cardiovascular Research Journal

The Official Annually Journal of Cardiovascular Research Center, Shiraz University of Medical Sciences

Current Issue All Issues In Press Accepted Manuscripts Search

Journal Information Boards & Committees Indexing and Listing Sources Journal Metrics Publication Ethics and Publication Malpractice Statement Contact Us Support Reviewer and AE Registration Form

APC

Authors Guide Submit Manuscript

Economic Burden of Cardiovascular disease in South West of Iran

Author(s):

Sara Emamgholipour¹,

Ali Akbari Sari¹,

Mohsen Pakdaman²,

Sara Geravandi^2,*

1Department of Health Management and Economics, School of Public Health, Tehran University of Medical Sciences, Iran

2Department of Health Care Management, School of Public Health, Shahid Sadoughi University of Medical Sciences, Yazd, Iran

International Cardiovascular Research Journal:Vol. 12, issue 1; e55067

Published online:Mar 01, 2018

Article type:Research Article

Received:Feb 13, 2018

Accepted:Jan 13, 2018

How to Cite:Sara EmamgholipourAli Akbari SariMohsen PakdamanSara GeravandiEconomic Burden of Cardiovascular disease in South West of Iran.Int Cardiovasc Res J.12(1):e55067.

Abstract

Background: CVDs are the first cause of death globally. About 50% of annual deaths are
related to this group of diseases in Iran; however, the economic cost of CVD on Iranian
society has not been conducted.
Objectives: The aim of this study was to estimate the economic burden of CVDs in the
southwest of Iran in 2016 from the social perspective.
Materials and Methods: This study is a cross-sectional descriptive-analytic study
conducted using the cost of illness (COI) framework. The prevalence top-down method
was used to quantify the annual cardiovascular costs. Productivity losses were estimated
using the human capital approach and the friction cost method, with the discount rate
of 3% to convert all future lifetime earnings into the present value.
Results: In 2016, the average total cost per patient was $1881.4 and the total costs resulted
in 1159.62 $million. Direct costs accounted for 60% and indirect costs for 40% of the total
costs. The results were robust to a 20% change in the average unit price of all medical and
non- medical direct costs and to discount rate of 2% and 10%.
Conclusions: The total cardiovascular disease costs in 2016 represented approximately
6.7% of the Iran gross domestic product. The results of this study would be of special help
for policymakers to evaluate the cost-effectiveness and outcomes of health care programs
to allocate health care resources efficiently. Primordial Prevention of CVD including
lifestyle modifications and dietary interventions resulted in substantial financial savings
and is strongly recommended.

Keywords

Cardiovascular Diseases

Cost of Illness

Iran

Fulltext

The full text is available in PDF.

References

1.
The references are available in PDF.

comments